End to End Service Tailored to Your Needs
Client Sample Case
Service: Full Study Management
Phase I, Therapeutic Vaccine for Chronic Hepatitis B
- Country: Philippines, 1 Site
- Study Start Up: 77 days (Submission to Site Activation including contract negotiation)
- Recruitment: Completed within 2 weeks for each Cohort (3 cohorts of 16 patients each)
- Retention: 100% Retention Rate
- DBL and COV: Achieved 3 weeks before original target.
- Normal Study Start up in Philippines takes an average of 160 days from submission to activation including importation, clearance and other activation requirements.
Client Sample Case
Service: Regulatory/Study Start Up
Phase III, COVID 19 Vaccine Study (AFTER PANDEMIC)
- Country: Philippines, 3 sites
- Study Start Up: 58 days (Submission to Study Clearance/IND)
- Normal Study Start up in Philippines takes an average of 120 days from submission to approval.
